Product Details

BACK TO PRODUCTS

Acalabrutinib

Product Name Acalabrutinib
Product Code A0000190
Chemical name Acalabrutinib
Synonyms 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196
Impurity
CAS Number 1420477-60-6
Alternate CAS # NA
Molecular form C₂₆H₂₃N₇O₂
Appearance
Melting Point
Mol. Weight 465.51
Storage
Solubility
Stability
Category
Boiling Point
Applications Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton’s tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).
Dangerous Goods Info NA
References Byrd; et al. (2015). "Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia."; "AstraZeneca to buy Acerta for blood cancer drug". www.rsc.org. Chemistry World - Royal Society of Chemistry. Retrieved 24 December 2015.
Extra Notes
Documents (MSDS) No Data Available
Keywords Buy 1420477-60-6 | Purchase 1420477-60-6 | Order 1420477-60-6 | 1420477-60-6 supplier | 1420477-60-6 manufacturer | 1420477-60-6 distributor | 1420477-60-6 cost
Acalabrutinib
Product Packings
2.5mg
5mg
10mg
25mg
100mg
250mg
Product Inquiry